Treatment of sexually transmitted vaginosis/vaginitis
- PMID: 2201078
- DOI: 10.1093/clinids/12.supplement_6.s665
Treatment of sexually transmitted vaginosis/vaginitis
Abstract
Although much has been learned about sexually transmissible forms of vaginitis/vaginosis during the past decade, therapeutic options for these disorders remain limited. A single 2-g oral dose of metronidazole still remains highly effective against most Trichomonas vaginalis infections. Mildly resistant infections can usually be cured with metronidazole oral doses of 2 g daily for 3-7 days. When highly resistant infections occur, toxic levels of metronidazole may be needed for the drug to cure the infection. Metronidazole (500 mg twice daily for 7 days) continues to be highly efficacious in the treatment of bacterial vaginosis. Shorter oral treatment regimens that use single 2-g doses of metronidazole for 2-3 days appear promising but may be associated with higher relapse rates. Oral clindamycin (300 mg twice daily) or local 2% clindamycin cream (once daily for 7 days) also may be effective. Metronidazole intravaginal sponges (250-1,000 mg) used for 3 days may also be effective in the treatment of bacterial vaginosis.
Similar articles
-
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.J Obstet Gynaecol Can. 2015 Mar;37(3):266-274. doi: 10.1016/S1701-2163(15)30316-9. J Obstet Gynaecol Can. 2015. PMID: 26001874
-
Clindamycin versus metronidazole in the treatment of bacterial vaginosis.Obstet Gynecol. 1989 Aug;74(2):281-2. Obstet Gynecol. 1989. PMID: 2748067 No abstract available.
-
[Metronidazole in the treatment and prevention of infections in gynecology and obstetrics].Zentralbl Gynakol. 1983;105(10):617-28. Zentralbl Gynakol. 1983. PMID: 6880463 German.
-
Treatment of bacterial vaginosis.Ann Pharmacother. 1994 Apr;28(4):483-7. doi: 10.1177/106002809402800412. Ann Pharmacother. 1994. PMID: 8038475 Review.
-
Metronidazole.Obstet Gynecol Clin North Am. 1992 Sep;19(3):497-510. Obstet Gynecol Clin North Am. 1992. PMID: 1436927 Review.
Cited by
-
Trichomonas vaginalis genital infections: progress and challenges.Clin Infect Dis. 2011 Dec;53 Suppl 3(Suppl 3):S160-72. doi: 10.1093/cid/cir705. Clin Infect Dis. 2011. PMID: 22080269 Free PMC article.
-
Finding a Balance in the Vaginal Microbiome: How Do We Treat and Prevent the Occurrence of Bacterial Vaginosis?Antibiotics (Basel). 2021 Jun 15;10(6):719. doi: 10.3390/antibiotics10060719. Antibiotics (Basel). 2021. PMID: 34203908 Free PMC article. Review.
-
A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.Clin Infect Dis. 2015 Dec 15;61 Suppl 8(Suppl 8):S837-48. doi: 10.1093/cid/civ738. Clin Infect Dis. 2015. PMID: 26602621 Free PMC article. Review.
-
Evaluation and management of vaginitis.J Gen Intern Med. 1998 May;13(5):335-46. doi: 10.1046/j.1525-1497.1998.00101.x. J Gen Intern Med. 1998. PMID: 9613891 Free PMC article. Review.
-
Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.Antimicrob Agents Chemother. 1995 Aug;39(8):1848-52. doi: 10.1128/AAC.39.8.1848. Antimicrob Agents Chemother. 1995. PMID: 7486930 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous